Scientific paper - Case study
Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab
Acta clinica Croatica, 62 (2023), 2; 382-385. https://doi.org/10.20471/acc.2023.62.02.19

Krečak, Ivan; Gverić-Krečak, Velka

Cite this document

Krečak, I. & Gverić Krečak, V. (2023). Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab. Acta clinica Croatica, 62. (2), 382-385. doi: 10.20471/acc.2023.62.02.19

Krečak, Ivan and Velka Gverić Krečak. "Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab." Acta clinica Croatica, vol. 62, no. 2, 2023, pp. 382-385. https://doi.org/10.20471/acc.2023.62.02.19

Krečak, Ivan and Velka Gverić Krečak. "Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab." Acta clinica Croatica 62, no. 2 (2023): 382-385. https://doi.org/10.20471/acc.2023.62.02.19

Krečak, I. and Gverić Krečak, V. (2023) 'Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab', Acta clinica Croatica, 62(2), pp. 382-385. doi: 10.20471/acc.2023.62.02.19

Krečak I, Gverić Krečak V. Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab. Acta clinica Croatica [Internet]. 2023 [cited 2024 September 30];62(2):382-385. doi: 10.20471/acc.2023.62.02.19

I. Krečak and V. Gverić Krečak, "Refractory Guillain-Barré Syndrome in a Patient with Asymptomatic Multiple Myeloma Successfully Treated with Low-Dose Rituximab", Acta clinica Croatica, vol. 62, no. 2, pp. 382-385, 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:287378. [Accessed: 30 September 2024]

Please login to the repository to save this object to your list.